Comprehensive Quantitative Evaluation of Inter-observer Delineation Performance of MR-guided Delineation of Oropharyngeal Gross Tumor Volumes and High-risk Clinical Target Therapy: An R-IDEAL Stage 0 Prospective Study
View ORCID ProfileCarlos E. Cardenas, View ORCID ProfileSanne E. Blinde, View ORCID ProfileSweet Ping Ng, View ORCID ProfileAbdallah S.R. Mohamed, View ORCID ProfileFrank Pameijer, View ORCID ProfileAlexis NTJ Kotte, View ORCID ProfileCornelis Raaijmakers, View ORCID ProfileBrigid A. McDonald, View ORCID ProfileAbrahim A. Al-Mamgani, View ORCID ProfileArash Navran, View ORCID ProfileOlga Hamming-Vrieze, View ORCID ProfileNicolien Kasperts, View ORCID ProfilePatricia Doornaert, View ORCID ProfileHoman Dehnad, View ORCID ProfileErnst J. Smid, Andrew J. Sykes, David Thomson, Lip Wai Lee, View ORCID ProfileAndrew McPartlin, View ORCID ProfileJared Robbins, Kate Newbold, View ORCID ProfileChris Nutting, View ORCID ProfileIrene Karam, View ORCID ProfileIan Poon, View ORCID ProfileMarielle Philippens, View ORCID ProfileHesham Elhalawani, View ORCID ProfileMona J Kamal, View ORCID ProfileMohamed AM Meheissen, View ORCID ProfileAdam Garden, William H. Morrison, View ORCID ProfileJack Phan, View ORCID ProfileG. Brandon Gunn, Steven J. Frank, View ORCID ProfileDavid I Rosenthal, View ORCID ProfilePierre Blanchard, View ORCID ProfileHouda Bahig, View ORCID ProfileClifton D. Fuller, View ORCID ProfileChris Terhaard
doi: https://doi.org/10.1101/2022.01.24.22269596
Carlos E. Cardenas
1University of Alabama-Birmingham, Birmingham, AL, USA
PhDSanne E. Blinde
2ZMV Klinikum Kassel, Kassel, Hesse, DE
MDSweet Ping Ng
3Austin Hospital, Melbourne, Victoria, AUS
MDAbdallah S.R. Mohamed
4The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MD MScFrank Pameijer
5University Medical Center-Utrecht, Utrecht, NL
MD PhDAlexis NTJ Kotte
5University Medical Center-Utrecht, Utrecht, NL
PhDCornelis Raaijmakers
5University Medical Center-Utrecht, Utrecht, NL
PhDBrigid A. McDonald
4The University of Texas MD Anderson Cancer Center, Houston, TX, USA
BSAbrahim A. Al-Mamgani
6Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, NL
MD PhDArash Navran
6Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, NL
MDOlga Hamming-Vrieze
6Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, NL
MDNicolien Kasperts
5University Medical Center-Utrecht, Utrecht, NL
MDPatricia Doornaert
5University Medical Center-Utrecht, Utrecht, NL
MD PhDHoman Dehnad
5University Medical Center-Utrecht, Utrecht, NL
MDErnst J. Smid
5University Medical Center-Utrecht, Utrecht, NL
MDAndrew J. Sykes
7The Christie NHS Foundation Trust, Withington, Manchester, UK
MDDavid Thomson
7The Christie NHS Foundation Trust, Withington, Manchester, UK
MDLip Wai Lee
7The Christie NHS Foundation Trust, Withington, Manchester, UK
MDAndrew McPartlin
7The Christie NHS Foundation Trust, Withington, Manchester, UK
MDJared Robbins
8University of Arizona, Tucson, AZ, USA
MDKate Newbold
9The Royal Marsden NHS Foundation Trust, Chelsea, London, UK
MDChris Nutting
9The Royal Marsden NHS Foundation Trust, Chelsea, London, UK
MD PhDIrene Karam
10Sunnybrook Hospital-Odette Cancer Center, Toronto, ON, CA
MD PhDIan Poon
10Sunnybrook Hospital-Odette Cancer Center, Toronto, ON, CA
MDMarielle Philippens
5University Medical Center-Utrecht, Utrecht, NL
MD PhDHesham Elhalawani
11Brigham & Women’s Hospital-Harvard Medical School, Boston, MA, USA
MDMona J Kamal
4The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MD PhDMohamed AM Meheissen
12Alexandria University, Alexandria, EG
MD PhDAdam Garden
4The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MDWilliam H. Morrison
4The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MDJack Phan
4The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MD PhDG. Brandon Gunn
4The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MDSteven J. Frank
4The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MDDavid I Rosenthal
4The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MDPierre Blanchard
13Institut Gustave-Roussy, Villejuif, Ile-de-France, FR
MD PhDHouda Bahig
14Centre hospitalier de l’Université de Montréal, Montreal, Quebec, CA
MDClifton D. Fuller
4The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MD PhDChris Terhaard
5University Medical Center-Utrecht, Utrecht, NL
MD PhDData Availability
Anonymized data are embargoed until peer-review completion, but thereafter available at https://doi.org/10.6084/m9.figshare.18822194
Posted January 25, 2022.
Comprehensive Quantitative Evaluation of Inter-observer Delineation Performance of MR-guided Delineation of Oropharyngeal Gross Tumor Volumes and High-risk Clinical Target Therapy: An R-IDEAL Stage 0 Prospective Study
Carlos E. Cardenas, Sanne E. Blinde, Sweet Ping Ng, Abdallah S.R. Mohamed, Frank Pameijer, Alexis NTJ Kotte, Cornelis Raaijmakers, Brigid A. McDonald, Abrahim A. Al-Mamgani, Arash Navran, Olga Hamming-Vrieze, Nicolien Kasperts, Patricia Doornaert, Homan Dehnad, Ernst J. Smid, Andrew J. Sykes, David Thomson, Lip Wai Lee, Andrew McPartlin, Jared Robbins, Kate Newbold, Chris Nutting, Irene Karam, Ian Poon, Marielle Philippens, Hesham Elhalawani, Mona J Kamal, Mohamed AM Meheissen, Adam Garden, William H. Morrison, Jack Phan, G. Brandon Gunn, Steven J. Frank, David I Rosenthal, Pierre Blanchard, Houda Bahig, Clifton D. Fuller, Chris Terhaard
medRxiv 2022.01.24.22269596; doi: https://doi.org/10.1101/2022.01.24.22269596
Comprehensive Quantitative Evaluation of Inter-observer Delineation Performance of MR-guided Delineation of Oropharyngeal Gross Tumor Volumes and High-risk Clinical Target Therapy: An R-IDEAL Stage 0 Prospective Study
Carlos E. Cardenas, Sanne E. Blinde, Sweet Ping Ng, Abdallah S.R. Mohamed, Frank Pameijer, Alexis NTJ Kotte, Cornelis Raaijmakers, Brigid A. McDonald, Abrahim A. Al-Mamgani, Arash Navran, Olga Hamming-Vrieze, Nicolien Kasperts, Patricia Doornaert, Homan Dehnad, Ernst J. Smid, Andrew J. Sykes, David Thomson, Lip Wai Lee, Andrew McPartlin, Jared Robbins, Kate Newbold, Chris Nutting, Irene Karam, Ian Poon, Marielle Philippens, Hesham Elhalawani, Mona J Kamal, Mohamed AM Meheissen, Adam Garden, William H. Morrison, Jack Phan, G. Brandon Gunn, Steven J. Frank, David I Rosenthal, Pierre Blanchard, Houda Bahig, Clifton D. Fuller, Chris Terhaard
medRxiv 2022.01.24.22269596; doi: https://doi.org/10.1101/2022.01.24.22269596
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (679)
- Anesthesia (182)
- Cardiovascular Medicine (2685)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12318)
- Forensic Medicine (10)
- Gastroenterology (771)
- Genetic and Genomic Medicine (4161)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2699)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3935)
- Nursing (213)
- Nutrition (586)
- Oncology (2073)
- Ophthalmology (596)
- Orthopedics (243)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1131)
- Primary Care Research (462)
- Public and Global Health (6583)
- Radiology and Imaging (1424)
- Respiratory Medicine (877)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (55)
- Transplantation (191)
- Urology (170)